• / Free eNewsletters & Magazine
  • / My Account
Home>Funds>iShares S&P North Amer Natural Resources

iShares S&P North Amer Natural Resources

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Research and Markets: Roche's Quilizumab (Asthma) - Forecast and Market Analysis to 2023

    Research and Markets: Roche's Quilizumab (Asthma) - Forecast and Market Analysis to 2023

  2. Research and Markets: AstraZeneca's Tralokinumab (Asthma) - Forecast and Market Analysis to 2023

    Research and Markets: AstraZeneca's Tralokinumab (Asthma) - Forecast and Market Analysis to 2023

  3. New Britain Palm Oil Gets GBP1.07 Billion Offer; Gresham Computing Warns

    New Britain Palm Oil Gets GBP1.07 Billion Offer; Gresham Computing Warns

  4. S&P 500: Bad Benchmark

    This article represents opinions of the author and not those of his firm and are subject to change from time to time and do not constitute a recommendation to purchase and sale any security nor to engage in any particular investment strategy. The information contained here has been obtained from ...

  5. The Elusive Diversified Natural-Resources Fund

    Finding a balanced equity natural-resources fund can be challenging.

  6. The Elusive Diversified Natural-Resources Fund

    Finding a balanced equity natural-resources fund can be challenging.

  7. An Overlooked Benefit of Active Natural Resources Funds

    These funds offer an unappreciated layer of diversification versus their ETF counterparts.

  8. An Overlooked Benefit of Active Natural Resources Funds

    These funds offer an unappreciated layer of diversification versus their ETF counterparts.

  9. ETF Opportunity in the Undervalued Natural-Resources Sector

    A low-cost, one-stop holding for diversified equity exposure to global natural resources. 

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.